Skip to Content

Daronrix

Active Substance: Whole virion, inactivated, containing antigen*: A/Vietnam/1194/2004 (H5N1) * produced in eggs
Common Name: Pandemic influenza vaccine (H5N1) (whole virion, inactivated, adsorbed)
ATC Code: J07BB01
Marketing Authorisation Holder: GlaxoSmithKline Biologicals S.A.
Active Substance: Whole virion, inactivated, containing antigen*: A/Vietnam/1194/2004 (H5N1) * produced in eggs
Status: Withdrawn
Authorisation Date: 2007-03-21
Therapeutic Area: Influenza, Human Immunization Disease Outbreaks
Pharmacotherapeutic Group: Vaccines

Therapeutic Indication

Prophylaxis of influenza in an officially declared pandemic situation. Pandemic influenza vaccine should be used in accordance with official guidance.

The marketing authorisation for Daronrix has lapsed because it has not been marketed in the European Union in the three years following the granting of the authorisation.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Hide